A detailed history of Pnc Financial Services Group, Inc. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 5 shares of VERA stock, worth $241. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5
Previous 25 80.0%
Holding current value
$241
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$34.09 - $46.71 $681 - $934
-20 Reduced 80.0%
5 $0
Q2 2024

Aug 09, 2024

BUY
$33.72 - $48.82 $269 - $390
8 Added 47.06%
25 $0
Q1 2024

May 10, 2024

BUY
$14.91 - $49.14 $223 - $737
15 Added 750.0%
17 $0
Q4 2023

Feb 09, 2024

SELL
$9.29 - $16.0 $1,904 - $3,280
-205 Reduced 99.03%
2 $0
Q2 2023

Aug 11, 2023

BUY
$6.11 - $17.83 $1,264 - $3,690
207 New
207 $3,000

Others Institutions Holding VERA

About Vera Therapeutics, Inc.


  • Ticker VERA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,042,300
  • Market Cap $1.31B
  • Description
  • Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...
More about VERA
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.